Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026)
Neuroone Medical Technologies (NMTC) posted Depreciation & Amortization (CF) of $60029.0 for Q1 2026, down 8.38% on a QoQ basis from $65523.0 in Q4 2025, and down 8.54% year-over-year from $65634.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $60029.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 8.54% year-over-year to $60029.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $256470.0 (down 0.59% YoY) and the FY2025 annual result came in at $261679.0, up 6.03% from the prior year.
- Depreciation & Amortization (CF) was $60029.0 for Q1 2026 at Neuroone Medical Technologies, down from $65523.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $66594.0 in Q2 2025 and bottomed at $28531.0 in Q1 2022.
- A 5-year average of $54514.5 and a median of $60900.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 87.03% — and 2026, when it fell 8.54%.
- Neuroone Medical Technologies' Depreciation & Amortization (CF) stood at $35889.0 in 2022, then soared by 63.44% to $58657.0 in 2023, then grew by 11.03% to $65127.0 in 2024, then gained by 0.61% to $65523.0 in 2025, then slipped by 8.38% to $60029.0 in 2026.
- Business Quant data shows NMTC's Depreciation & Amortization (CF) at $60029.0 in Q1 2026, $65523.0 in Q4 2025, and $64324.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 60,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,029.00 |
| Mar 31, 2026 | 60,029.00 |
| Dec 31, 2025 | 65,523.00 |
| Dec 31, 2025 | 65,523.00 |
| Sep 30, 2025 | 64,324.00 |
| Sep 30, 2025 | 64,324.00 |
| Jun 30, 2025 | 66,594.00 |
| Jun 30, 2025 | 66,594.00 |
| Mar 31, 2025 | 65,634.00 |
| Mar 31, 2025 | 65,634.00 |
| Dec 31, 2024 | 65,127.00 |
| Dec 31, 2024 | 65,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Jun 30, 2024 | 63,107.00 |
| Jun 30, 2024 | 63,107.00 |
| Mar 31, 2024 | 60,900.00 |
| Mar 31, 2024 | 60,900.00 |
| Dec 31, 2023 | 58,657.00 |
| Dec 31, 2023 | 58,657.00 |